Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

NCT04382586 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pulmonary Complications
COVID-19

Interventions

DRUG: Zanubrutinib
DRUG: Supportive Care
DRUG: Placebo

Sponsor

BeiGene